https://www.selleckchem.com/pr....oducts/Temsirolimus.
79, 95% CI 1.08-2.97 for highest vs lowest quartile, P values for trend=0.045). Likewise, increasing changes in VAT area were independently associated with a higher risk of recurrent adenoma (HR 1.35, 95% CI 1.13-1.62 for change per 10cm increase; HR 1.62, 95% CI 1.04-2.52 for highest vs lowest quartile, P values for trend=0.001). Changes in subcutaneous adipose tissue area were not independently associated with CRA. Increasing changes in VAT area were longitudinally associated with a higher risk of incident and recurrent CRA, inde